urea. The extent of protein carbamylation in vitro Background. Carbamylation is an irreversible process depends on both the duration of exposure to and of non-enzymatic modification of proteins by the absolute concentration of urea [1]. As a consequence, breakdown products of urea. For haemoglobin (Hb), proteins of uraemic patients are carbamylated to a the extent of carbamylation is a marker of urea expo-greater extent than those of patients with normal renal sure and has been proposed as an indicator of the function [2]. The time dependence for carbamylation control of uraemia by dialysis, analogous to the use of of the haemoglobin (Hb) protein in vivo is reflected in Hb glycosylation in diabetic patients.
Introduction

Measurement of CarbHb
Subjects and methods
Blood for measurement of CarbHb was collected in 5-ml
Patients tubes containing lithium-heparin. CarbHb was measured by the method described by Kwan et al. [16 ] . Briefly, carbamyl All the patients in this analysis were stable outpatients who valine was released from washed erythrocytes after hydrolysis had been on dialysis for at least 2 months. The study with a mixture of acetic and hydrochloric acid. Valine population was drawn from a city suburban community and hydantoin ( VH ), formed after the spontaneous dissociation was predominantly Caucasoid in ethnicity (eight Asian of carbamyl valine, was extracted and quantitated by highpatients were included). Six patients who were non-compliant performance liquid chromatography, with results expressed with HD were excluded from assessment because of the lack as mg VH/g Hb. of reliable adequacy data. Two patients who received a blood transfusion in the 3 months prior to measurement of CarbHb were also excluded. None of the patients included was known Statistical methods to have a haemoglobinopathy. Blood for measurement of CarbHb was drawn consecutively from all patients over a Statistical analysis was performed using a computer-based 3-month period at the time of a routine 6-monthly assessment statistics program (Statistical Package for Interactive Data of dialysis adequacy.
Analysis, Statistical Computing Laboratory, Sydney, Australia). Using CarbHb as the dependent variable, univariate linear regression was performed on all potential predictors using Pearson's or Spearman's correlation tests as appro-
Dialysis method
priate. The 't test' was used to compare dichotomous variables and patient subgroups. Because of the likelihood that HD patients in this study were undergoing thrice-weekly some of the univariate correlates were co-dependent, multiva-'low-flux' maintenance dialysis. HD was performed with riate analysis was used to model CarbHb. Multivariate data modified cellulose (Baxter, Illinois, USA) or polysulphone are expressed as b coefficient, standard error (SE), and (Fresenius AG, Bad Homburg, Germany) membranes, using probability. a bicarbonate-based buffer of 40 mmol/l. Treatment times varied between 4 and 6 h per session (mean 5.1 h). PD patients were undergoing maintenance PD at home using a Results dextrose-containing dialysate (Baxter, Illinois, USA).
HD patients
CarbHb was collected in a total of 80 HD patients.
Dialysis adequacy
CarbHb levels as well as patient characteristics, HD patients Blood was drawn at the start of the mid-week adequacy measurements, and biochemical parameters dialysis session for routine estimation of pre-dialysis serum for these patients are shown in Table 1 . As a group urea, albumin, phosphate, and bicarbonate. Post-dialysis they appeared to be well dialysed (mean Kt/V 1.47, urea was measured at the same session using the 'slow-flow' mean URR 70%, mean albumin 40.2 g/l ) with signimethod. This involved sampling blood from the 'arterial' ficantly higher CarbHb levels than the normal range.
line 2 min after reducing the blood pump speed to 50 ml/min Univariate analysis ( CarbHb was also significantly correlated with serum Kt/V=−L n(R−0.008×t)+(4−3.5×R)×UF/W bicarbonate in the 33 patients in whom bicarbonate was measured (r=−0.40, P<0.05). The group of where R is the post-dialysis/pre-dialysis urea ratio, t is the patients in whom bicarbonate was measured did not treatment time (h), UF is the ultrafiltrate quantity ( l ) and statistically differ from the remainder of patients in W is the post-dialysis weight (kg). For the six patients in any of the measured variables. Kt/V did not correlate whom significant residual renal function existed (defined as with CarbHb when examined as a continuous variable passage of greater than 100 ml urine daily), this was incorpor-(P=0.18). Subdivision of patients into groups based ated into the measurement of Kt/V as described by Gotch and Keen [13] .
on their estimated Kt/V did not result in any significant Normalized protein catabolic rate (nPCR) was estimated change of CarbHb values (P=0.13 for Kt/V<1.2 vs using the nomographic method of Daugirdas and Depner Kt/V>1.6, P=0.59 for Kt/V<1.2 vs Kt/V>1.2). [14] .
CarbHb levels also did not correlate with URR (P= PD patients Blood was drawn at the time of dialysis adequacy 0.29), serum phosphate (P=0.28), patient age (P= for routine measurement of serum urea, albumin, phosphate, 0.25), gender (P=0.40), or months of dialysis (P= and bicarbonate. Estimations of Kt/V (weekly), corrected 0.52). CarbHb levels also did not differ significantly in creatinine clearance (CrCl ), and residual renal function patients with residual renal function (P=0.60). Weekly Univariate analysis ( Table 4) identified a statistically significant correlation between CarbHb and serum urea (r=0.51, P=0.001) and nPCR (r=0.52, P= 0.01). No correlation was found for patient factors Forty-two patients (53%) were receiving subcutaneous erythropoietin (rHuEpo) therapy. CarbHb levels (age (P=0.68), gender (P=0.43), months of dialysis (P=0.97)), adequacy measures (weekly Kt/V (P= did not differ between these patients and the 38 patients managed without rHuEpo (P=0.09) and the total 0.78), corrected CrCl (P=0.58)), or biochemical parameters (albumin (P=0.43), phosphate (P=0.86), weekly dose of rHuEpo did not appear to affect CarbHb levels (P=0.71). Based on Hb levels collected bicarbonate (P=0.75)). The extent of residual renal function measured by urea clearance similarly did not 3 months prior to measurement of CarbHb, the change in Hb levels over time did not differ between groups correlate with CarbHb levels (P=0.13).
Sixteen patients (38%) were receiving rHuEpo (mean Hb change in patients receiving rHuEpo +0.24±1.129 g/l vs −0.13±1.08 g/l in patients man-therapy. CarbHb levels did not differ between these patients and the 26 patients managed without rHuEpo aged without rHuEpo).
Because of co-dependency of many of the variables (P=0.09) and the total weekly dose of rHuEpo did not appear to affect CarbHb levels (P=0.71). Based measured, multivariate analysis with backward elim- between CarbHb and urea is supported by the findings of a previous smaller study [2] . In PD patients the correlation coefficient for urea and CarbHb is slightly In this study, CarbHb levels were found to be significantly higher in HD patients with higher serum albumin, a finding that has not been previously Serum are associated both with lower urea levels and lower levels of serum albumin, an established predictor of patient mortality [8, 18] . This relationship did not on Hb levels collected 3 months prior to measurement appear in the PD patients in this analysis, possibly of CarbHb, the change in Hb levels over time did not because of the smaller number of patients studied. differ between groups (mean Hb change in patients Alternatively, it has been suggested that albumin levels receiving rHuEpo −0.05±1.06 g/l vs −0.01±0.74 g/l are less useful as a marker of nutritional status in PD in patients managed without rHuEpo).
patients [19, 20] , due to the loss of albumin in the Using multivariate analysis ( Table 5) , serum urea peritoneal effluent. was the only independent predictor of CarbHb identiThis study found a weak negative association fied (Figure 2 ), presumably because of the significant between CarbHb and bicarbonate in HD patients, as co-dependence of urea and nPCR.
has been previously reported [10] . Bicarbonate was measured in 33 of the 80 patients, but this group did not appear statistically distinct in terms of any of the Discussion other measured variables. This result suggests an effect of acidosis independent of urea to increase CarbHb. This study of both PD and HD patients confirmed a The cause of this finding is unclear, but as previous relationship between urea and a single measure of studies in HD patients have associated acidosis with CarbHb in vivo, but found no relationship between increased nPCR and dietary protein intake [21] , it is CarbHb and conventional measures of dialysis possible that this effect may relate to increased generaadequacy. Serum albumin and bicarbonate appear to tion of urea in acidotic HD patients. be independent predictors of CarbHb in HD patients.
In both groups of dialysis patients, treatment with The correlation with urea in both groups of patients rHuEpo did not appear to effect CarbHb levels signiis not unexpected, given the concentration and time ficantly. In the study by Davenport et al. [5] the group dependence of the carbamylation process in vitro [1] . receiving rHuEpo had both significantly lower CarbHb This result is in agreement with previous studies of levels and significantly higher reticulocyte counts, a HD patients, which showed a relationship between result attributed to the contribution of newly syntheCarbHb and both pre-dialysis urea [1, 10, 17] and sized and unexposed Hb proteins to the total Hb pool. the time-averaged concentration of urea ( TAC urea ) Interestingly, we found that the stability of Hb over the 3 months prior to CarbHb measurement did not use in monitoring uraemia in dialysis patients. This study found no relationship between CarbHb CarbHb as a predictor of patient outcome has not been examined in detail, however. The available and conventional measures of dialysis dose in either HD or PD patients. This result is at variance with information comes from two previous small comparisons of CarbHb levels in patients dying over a short previous smaller studies of HD patients in which a relationship was found between CarbHb and both period of follow-up compared with their surviving counterparts [5, 10] . The results of these analyses were Kt/V [5] and the URR [5,10], and has not been previously described in PD patients. Reasons for the conflicting (Davenport found higher levels of CarbHb in patients who died, and Tarif found no difference); discordance between this result and those of earlier studies in HD patients are unclear, despite similar however, the small numbers of patients examined makes the interpretation of these results hazardous. levels of CarbHb. Significantly, the achieved Kt/V and URR were higher in this study than in previous studies Large longitudinal studies of sufficient power to resolve a relationship between repeated measures of CarbHb where a correlation was found, and it is possible that a relationship between CarbHb and measurements of and outcome are not available.
In summary, CarbHb is a marker of uraemia in urea removal may be weaker at a higher achieved dose. It is also possible that the composition of the dialysis both HD and PD patients, but several lines of evidence suggest that a single measure is unlikely to be a useful membranes will contribute to the observed differences, as this study used modified cellulose or polysulphone index of dialysis adequacy. Whether CarbHb has any utility as a predictor of patient outcome or is just a membranes as opposed to the cellulose acetate membranes of earlier studies. Finally, earlier studies did surrogate measure of urea will remain unclear until large, longitudinal studies are performed. not submit the correlation to multivariate analysis, possibly leading to the error of confounding. of the dialysis patient series reported to date. Urea is a poor surrogate as a uraemic toxin, both because of the fact that its rate of generation varies with the
